Cellromax Science

471820 · KOSDAQ · ₩471820 · 셀로맥스사이언스

₩3,995▲ ₩30 (0.76%)End-of-day · Oct 30, 2026 · End-of-day prices.
Trade
Alert me

Income statement

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025
Revenue₩5.1B₩4.7B₩4.5B₩5.3B₩6.5B₩5.9B
Cost of sales₩2.3B₩2.2B₩2.7B₩2.6B₩3.3B₩3B
Gross profit₩2.8B₩2.5B₩1.8B₩2.7B₩3.1B₩2.9B
Operating income₩981M₩348M₩86M₩737M₩1.2B₩853M
Net income₩804M₩1.2B₩2.2B−₩398M₩416M₩739M
Net income to shareholders₩804M₩1.2B₩2.2B−₩398M₩416M₩739M

Balance sheet

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025
Total assets₩51B₩52B₩51B₩47B₩48B₩49B
Current assets₩15B₩16B₩14B₩13B₩19B₩23B
Cash and equivalents₩3.4B₩3.2B₩678M₩5.7B₩2.4B₩1.2B
Total liabilities₩3.6B₩4.4B₩4B₩3.8B₩4.6B₩6.4B
Current liabilities₩2.6B₩3.2B₩2.8B₩3.3B₩3.1B₩4.8B
Borrowings————₩1B₩993M
Total equity₩47B₩48B₩47B₩43B₩44B₩43B
Shareholders' equity₩47B₩48B₩47B₩43B₩44B₩43B

Cash flow

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025
Cash from operations₩1.3B₩1.6B−₩356M−₩388M₩1.3B₩1.3B
Capital spending₩1.7M₩14M₩10M₩23M₩31M₩15M
Free cash flow₩1.3B₩1.6B−₩366M−₩411M₩1.2B₩1.2B
Dividends paid——₩396M₩1.1B——

Consolidated where available. Amounts in won.

Also known as: Cellromax Science / 셀로맥스사이언스 / 471820 / KRX:471820

Source: KRX statistical information